Ron Lanton Featured in Reuters on Global Drug Pricing and Market Strategy

Written By Ron Lanton

Recent coverage in Reuters highlights how U.S. pricing policy is beginning to influence global launch strategy for pharmaceutical companies.

The article examines how manufacturers are adjusting decisions across markets in response to policy pressure and evolving reimbursement dynamics. Click here to view the article.

Ron Lanton
Next

Mergers and Acquisitions Are Not About the Deal